StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1241
This month
14
This week
6
This year
109
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
5
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 08 - 31
4
2021 - 08 - 25
4
2021 - 08 - 19
5
2021 - 08 - 05
6
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 04 - 13
4
2021 - 03 - 18
5
Sector
Commercial services
12
Communications
8
Consumer durables
5
Consumer non-durables
15
Consumer services
2
Distribution services
4
Electronic technology
19
Finance
6
Health care and social assistance
1
Health services
17
Health technology
1241
Industrial services
1
Information
4
Manufacturing
136
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
16
Producer manufacturing
22
Professional, scientific, and technical services
20
Retail trade
3
Technology services
17
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
115
Drug delivery
11
Earnings
21
Europe
17
Expansion
11
Expected
35
Eye
21
Fda
28
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
262
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
599
N/a
1115
Novartis
133
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
19
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
11
Sclerosis
13
Set
16
Study
17
T-cell
12
Technology
14
Therapeutics
114
Therapy
89
Treatment
137
Trial
25
Vaccine
16
Year
12
Entities
3m company
938
Abb ltd
1427
Abbott laboratories
1787
Abbvie inc.
1024
Accenture plc
600
Alphabet inc.
781
Apple inc.
546
Arcelormittal
589
Arrival
586
Bank of montreal
539
Baxter international inc.
483
Becton, dickinson and company
796
Bnp paribas
654
Boston scientific corporation
575
Bristol-myers squibb company
662
Cisco systems, inc.
532
Cummins inc.
542
Danaher corporation
785
Dell technologies inc.
576
Dow inc.
556
Duke energy corporation
527
Eli lilly and company
1709
Ericsson
545
Express, inc.
509
Firstenergy corp.
517
Ford motor company
641
Gartner, inc.
594
General electric company
917
Glaxosmithkline plc
884
Honeywell international inc.
1787
Hubspot, inc.
1400
International business machines corporation
655
Johnson & johnson
4583
Johnson controls international plc
481
Koninklijke philips n.v.
962
Live nation entertainment, inc.
717
Lockheed martin corporation
575
Medtronic plc
1285
Microsoft corporation
807
Morgan stanley
4286
Nabors industries ltd.
480
Nokia corp
904
Nokia corporation
901
Northrop grumman corporation
589
Novartis ag
1241
Novo nordisk a/s
632
Ooma, inc.
488
Oracle corporation
1158
Orange
1423
Pfizer, inc.
692
S&p global inc.
500
Sanofi
1630
Sap se
1477
Snowflake inc.
796
Stellantis n.v
535
Stryker corporation
536
Thermo fisher scientific inc
1623
Transunion
533
Verizon communications inc.
1213
X financial
676
Symbols
ABBV
239
ABT
119
ADAP
15
ALC
15
ALKS
10
ALPMF
70
ALPMY
70
AMGN
196
AZN
198
AZNCF
171
BAX
48
BDX
19
BHC
74
BIIB
54
BLUE
11
BMY
103
BNTX
10
BSX
17
CMXHF
9
CSLLY
9
DHR
11
ENDP
20
ENDPQ
16
GIFLF
10
GIKLY
10
GILD
28
GLAXF
264
GMAB
21
GNMSF
12
GSK
304
INCY
21
IONS
9
JAZZ
14
JNJ
245
LLY
138
MDT
36
MMM
13
MNK
17
MNKKQ
16
MNKPF
13
MOR
15
MPSYF
12
NVO
28
NVS
1241
NVSEF
1031
ORTX
9
PFE
88
PHG
19
QURE
12
RBGLY
9
REGN
13
RGNX
12
SNY
329
SNYNF
284
SYK
12
TAK
58
TEVJF
206
TMO
51
VTRS
120
XNCR
11
Exchanges
Amex
7
Nasdaq
1156
Nyse
1241
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 08
6
2023 - 10 - 04
5
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 09 - 01
4
2021 - 08 - 25
4
2021 - 08 - 19
5
2021 - 08 - 05
6
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 04 - 13
4
2021 - 03 - 18
5
Crawled Time
00:00
45
00:20
10
01:00
47
01:08
1
02:00
25
03:00
34
04:00
23
04:20
8
05:00
23
06:00
69
06:03
2
07:00
39
08:00
34
08:20
4
08:23
1
09:00
45
10:00
33
11:00
52
11:01
1
12:00
83
12:15
6
12:20
16
12:30
9
13:00
35
13:14
1
13:15
7
13:20
8
13:30
5
13:35
1
13:58
1
14:00
50
14:15
2
14:20
10
14:30
7
14:49
1
15:00
55
15:15
4
15:20
16
15:30
16
16:00
56
16:01
1
16:20
4
17:00
65
18:00
55
19:00
45
20:00
48
20:20
3
21:00
34
22:00
55
22:01
1
23:00
44
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
spacfeed.com
1
www.biospace.com
126
www.globenewswire.com
226
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
880
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Novartis ag
exchanges :
Nyse
save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-4.36%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.28%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.67
-2.73%
-2.87%
570K
|
Health Technology
|
-4.57%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.28%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
-2.52%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.82
-1.74%
-1.83%
640K
|
Health Technology
|
1.9%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-1.51%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
$5.22
-10.92%
-12.26%
9.1M
|
Health Technology
|
-3.1%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-0.47%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-0.85%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.16%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.9%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
-0.46%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-0.68%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.22%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.57%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$34.78
1.43%
1.41%
940K
|
Health Technology
|
-7.45%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.49%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.57%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
0.31%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-10.96%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.16%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-10.79%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-5.12%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-9.54%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.71%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.25%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-7.38%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.57%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-5.76%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.83%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.88%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-16.04%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-1.64%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.02%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.21%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
$28.42
-0.41%
29K
|
n/a
|
-3.18%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-1.43%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.41%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
1.15%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$19.98
2.78%
2.7%
140K
|
n/a
|
-10.51%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.42%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.42%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.59
-4.14%
-4.32%
10K
|
Health Technology
|
41.72%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.55
1.38%
-0.25%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.14%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.45%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.42%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.06%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.47%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.01%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.79
0.0%
570K
|
|
-6.31%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
62
63
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.